Journal profile · Medicine-Neurology (clinical)

Annals of Clinical and Translational Neurology

ISSN 2328-9503 · John Wiley and Sons Inc. · UNITED STATES

Annals of Clinical and Translational Neurology: CAS Zone 2 · Medicine (2025 upgraded edition); impact factor 3.9; fully open access; APC about USD 4,100; median 79 days to acceptance (93 articles, last 24 months); acceptance rate 21% (journal website); 356 articles in 2025; indexed in SCIE and Scopus.

Impact factor3.9Latest value listed by LetPub
CAS zoneZone 2 · Medicine2025 upgraded edition, major category · 2026 Xinrui edition Zone 2 · Medicine
Review time79 daysMedian, submission to acceptance · 93 articles, last 24 months · Crossref
APCUSD 4,100Fully open access
Acceptance21%From the journal's website (2025)
Articles per year3562025 · OpenAlex count

Scope

Aims, scope and focus

Annals of Clinical and Translational Neurology is published by John Wiley and Sons Inc. and is in Zone 2 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Multiple Sclerosis Research Studies, Amyotrophic Lateral Sclerosis Research and Genetic Neurodegenerative Diseases, together about 25.9% of its articles. Its main subfields are Neurology. (generated from OpenAlex topic counts and CAS ranking data)

<em>Annals of Clinical and Translational Neurology</em> is an ANA journal publishing original research and reviews on the mechanisms and treatments of diseases of the nervous system.

From the journal's Aims & Scope

Research area (LetPub): Medicine-Neurology (clinical)

Editor-in-chief AHMET HOKEPublisher website

Editorial board by country: 1 in mainland China (about 9%); most named United States 9, Mainland China 1, Lebanon 1 (11 members with a country) Editorial board ↗Publisher website ·

Main research topics OpenAlex counts of recent articles; shares are approximate

  1. Multiple Sclerosis Research StudiesMedicine10.3%
  2. Amyotrophic Lateral Sclerosis ResearchMedicine8.3%
  3. Genetic Neurodegenerative DiseasesNeuroscience7.3%
  4. Epilepsy research and treatmentMedicine6.6%
  5. Parkinson's Disease Mechanisms and TreatmentsMedicine5.9%
  6. Peripheral Neuropathies and DisordersMedicine5.6%
  7. Neurological disorders and treatmentsMedicine5.2%
  8. Alzheimer's disease research and treatmentsMedicine4.8%

Rankings & indexing

CAS ranking and database indexing

CAS Journal Ranking

CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 2
LevelCategoryZone
MajorMedicineZone 2
MinorClinical NeurologyZone 2
MinorNeurosciencesZone 2

Top journal: noReview journal: no

CAS Xinrui Journal Ranking (March 2026)Medicine Zone 2
LevelCategoryZone
MajorMedicineZone 2
MinorClinical NeurologyZone 2
MinorNeurosciencesZone 2

Top journal: noReview journal: not marked

CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 2
LevelCategoryZone
MajorMedicineZone 2
MinorClinical NeurologyZone 2
MinorNeurosciencesZone 2

Top journal: noReview journal: no

Database indexing

SCIEScopusDOAJLetPub

International journal early-warning lists: not listed in any editionLetPub

Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.

Metrics

Impact metrics and publication volume

Impact

Impact factor
3.9LetPub ·
Impact factor (publisher) 2025
3.9Publisher website ·
CiteScore 2026-06
6.7LetPub ·
CiteScore (publisher) 2025
6.7Publisher website ·
SJR 2026-06
1.65LetPub ·
SNIP 2026-06
1.19LetPub ·
h-index
30LetPub ·
h-index
100OpenAlex ·
i10-index
1,557OpenAlex ·
2-year mean citedness
3.88OpenAlex ·
Self-citation rate
2.6%LetPub ·
Share of gold OA articles
100%LetPub ·

Volume

Articles per year
309LetPub ·
Articles per year (publisher) 2025
321Publisher website ·
Downloads per year (publisher) 2025
998,073Publisher website ·

Articles by year OpenAlex count · 2,988 in total · the current year is incomplete

YearArticlesOpen accessCitations
202624924980
20253563561,024
20243163162,465
20232682683,318
20222442444,606
20212242245,392

Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.

Review & acceptance

Review time and acceptance

Review time from article dates manuscript dates registered with Crossref · to

79 daysMedian, submission to acceptance · P25–P75 54 days – 116 days

Acceptance to online
median 26 days (93 articles)
Submission to online
median 105 days
Sample
93 articles with submission and acceptance dates (664 in the window); the latest was accepted on

Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".

Other sources

Average review time (community reports)
about 8 weeksLetPub ·
Acceptance rate (publisher) 2025
21%Publisher website ·
Submission to first decision 2025
4 daysPublisher website ·
Submission to final decision
42 daysPublisher website ·
Submission to acceptance 2025
80 daysPublisher website ·
Acceptance to publication 2025
28 daysPublisher website ·
Submission to publication (journal-reported)
about 8 weeksDOAJ ·
Peer review
Single anonymous peer reviewDOAJ

Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.

Fees & open access

APC and open-access policy

Fully open accessDOAJ

Every article is open access; authors usually pay an article processing charge (APC).

SourceAPCFee waiverLicenseObserved
DOAJUSD 4,100 / GBP 2,640 / EUR 2,990YesCC BY, CC BY-NC-ND
OpenAlexUSD 4,100 / EUR 2,990 / GBP 2,640——
LetPubUSD 3,850 / GBP 2,480 / EUR 2,810Yes—

The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.

Profile

Publication details and official links

Publisher
John Wiley and Sons Inc.
Country or region
UNITED STATES
Language
English
ISSN
2328-9503
Society / sponsor
American Neurological Association and the Child Neurology Society
Latest issue on the website
Volume 13, Issue 9 (September 2026)
Official links

FAQ

Frequently asked questions about Annals of Clinical and Translational Neurology

What CAS zone is Annals of Clinical and Translational Neurology in?

In the 2025 upgraded edition of the CAS Journal Ranking, Annals of Clinical and Translational Neurology is in Zone 2 of Medicine, and in Zone 2 of the minor category Clinical Neurology / Neurosciences. In the 2026 Xinrui edition it is in Zone 2 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.

What is the impact factor of Annals of Clinical and Translational Neurology?

The latest impact factor listed by LetPub is 3.9; CiteScore 6.7, h-index 100.

How long does peer review take at Annals of Clinical and Translational Neurology?

Based on the dates recorded on 93 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 79 days (interquartile range 54–116 days); authors report an average review time of about 8 weeks; the journal's website gives an acceptance rate of 21% (2025). Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.

Where are the editorial board members of Annals of Clinical and Translational Neurology based?

Of the 11 board members whose country the journal's board page names, 1 (about 9%) are in mainland China; the countries named most often are United States (9), Mainland China (1) and Lebanon (1). Counted from the institutions listed on the board page; for reference only.

Which databases index Annals of Clinical and Translational Neurology?

According to LetPub and DOAJ records, Annals of Clinical and Translational Neurology is indexed in SCIE, Scopus and DOAJ.

Is Annals of Clinical and Translational Neurology open access, and what is the APC?

Annals of Clinical and Translational Neurology is a fully open-access journal. APC about USD 4,100.

Sources and updates

The facts on this page come from LetPub, Publisher website, OpenAlex, DOAJ; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-25). Last updated: .